From conception to childbirth, there are many physical, hormonal, and psychological changes that a woman undergoes during pregnancy. During this time, balance is also affected, resulting in symptoms like vertigo and unsteadiness. These symptoms can lead to physical impairment and disability and can develop at any time. Vertigo in pregnancy has not been extensively written about. The subject of a narrative review is vertigo in pregnant patients. In pregnant women, hormonal alterations in the peripheral tissues and inner ear organs may contribute to vertigo. Meniere's disease, mild convulsive positional dizziness, and oculomotor migraines are all commonly exacerbated by pregnancy. Between the second and third trimesters of pregnancy, specific modifications to proprioception and hearing are also detected during physical examination. Patients who are pregnant typically experience these symptoms throughout this time. Some vertigo conditions can worsen during pregnancy, while others can appear at any time. Understanding audiovestibular symptoms' pathological and clinical relationship during pregnancy requires more study.
McKusick-Kaufman syndrome is a rare genetic disorder that affects limb development, genital formation, and heart function. It is caused by mutations in the MKKS gene on chromosome 20. Individuals with this condition may have extra fingers or toes, fused labia or undescended testes, and, less commonly, severe heart defects. Diagnosis involves a physical examination and genetic testing, while treatment focuses on symptom management, including surgical intervention if necessary. The prognosis varies depending on the severity of associated complications. In a recent case, a 27-year-old woman with fetal hydrometrocolpos gave birth to a female neonate with extra digits on both hands and feet, fused labia, and a small vaginal opening. The neonate also had a large abdominal cystic mass, and echocardiography revealed a patent foramen ovale. Genetic testing confirmed an MKKS gene mutation, and the hydrometrocolpos required surgical management. Early diagnosis and intervention can improve outcomes for individuals with this syndrome.
Systemic Lupus Erythematosus (SLE) is a fairly common and widespread condition. Currently, it is clinically relevant in most healthcare facilities and is discussed in both the medical and scientific literature. There is a wealth of data from both clinicians and researchers studying the problems and treatment options associated with SLE. Systemic lupus erythematosus is characterized by clinical variability, irregular course, and relapses (SLE). Although SLE is primarily a systemic autoimmune disease, it can sometimes be organ-specific, creating diagnostic difficulties. B-cell activating factor (BAFF) is attacked by belimumab (a monoclonal antibody), which reduces the level of BLys (B-lymphocyte stimulating cell), which is a chief cytokine in the pathophysiology of SLE. In our review of the literature, we tried to determine the efficacy and safety of the drug belimumab in the context of patients with SLE and how it affects their recovery and management. We have reviewed the two studies which were conducted regarding the role of this drug which was found to be promising and beneficial for seeking a new treatment route for the clinicians. Also, we have described different domains of the study and their mathematical results regarding the efficacy of the drug henceforth. We seek to describe the safest use and the best possible results that clinicians can achieve when treating patients with SLE, and we provide high levels of clinical care at the highest level. We advise physicians to monitor all areas of the drug's activity and to make educated and informed judgments, which are principally discussed in our article.
Background: There have been over 86 million global confirmed cases to date, and the disease is known to have a 2.2% case fatality rate, having claimed over 1.87 million lives. They were initially regarded as a purely respiratory disease with symptoms of viral pneumonia such as fever, fatigue, dry cough, and lymphopenia. The widespread coronavirus disease is aimed at the Arial route of the tramsmission. Furthermore, the constant mutations in the virulence factors of the virus lead to the effectiveness of the treatment regimens. Covid-19 disease is mainly known to be a pulmonary infection, giving rise to pulmonary fibrosis, focuses and leads to severe pneumonia and ulyimately gives a fatal result iof not treated promptly. The pulmonary but extrapulmonary manifestations of this disease are also seen—cardiovascular, renal, nervous and dermatological, and immune system. The exact pathogensis and the etiology of the extra pulmonary manifestation of covid to the cutaneous prognosis are not yet well known. The virulence factors, the antigens of the virus that exacerbate the dermatological symptoms. The virus causes dermatological symptoms in urticarial rashes, eczematous infections, and mucocutaneous depositions. The exact mechanisms of the disease’s progress to the dermatological variant are not known; however, this review will concentrate on the cutaneous manifestations of Covid-19 disease and the variant nature of the infection. The widespread coronavirus disease is aimed at the Arial route of transmission. Furthermore, the constant mutations in the virulence factors of the virus lead to the in effect ness of the treatment regimens. Covid-19 disease is mainly known to be a pulmonary infection, giving rise to pulmonary fibrosis, focuses and leads to severe pneumonia and ultimately gives a fatal result iof not treated promptly. The pulmonary but extrapulmonary manifestations of this disease are also seen—cardiovascular, renal, nervous dermatological and immune system. The exact pathogenesis and the etiology of the extrapulmonary manifestation of covid to the cutanenous prognosis is not yet well known. The virulence factors, the antigens of the virus that exacerbate the dermatological symptoms. The virus causes dermatological symptoms in urticarial rashes, eczematous infections, and mucocutaneous depositions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.